Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-005390
Filing Date
2025-01-13
Accepted
2025-01-13 17:27:51
Documents
6

Document Format Files

Seq Description Document Type Size
1 DFAN14A d866658ddfan14a.htm DFAN14A 106269
2 GRAPHIC g866658866658_01.jpg GRAPHIC 9063
3 GRAPHIC g866658866658_02.jpg GRAPHIC 9150
4 GRAPHIC g866658g05a01.jpg GRAPHIC 177025
5 GRAPHIC g866658g07a01.jpg GRAPHIC 234431
6 GRAPHIC g866658g09a01.jpg GRAPHIC 207964
  Complete submission text file 0001193125-25-005390.txt   984087
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filed by) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1229
Type: DFAN14A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 135 ROUTE 202/206 SUITE 6 BEDMINSTER NJ 07921
Business Address 135 ROUTE 202/206 SUITE 6 BEDMINSTER NJ 07921 (646) 440-9333
Intra-Cellular Therapies, Inc. (Subject) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-36274 | Film No.: 25527147
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)